Sage Stock Symbol Market Analysis and Forecasting

Sage stock symbol is SGRY on the NASDAQ exchange.

Sage Group is a global leader in accounting, financial, HR, and payroll software.

Sage's financial performance has been strong, with revenue growth of 12% in the last reported quarter.

The company's market capitalization is around $8 billion.

Sage's stock price has been relatively stable, with a 52-week range of $26.50 to $34.50.

Sage's financial health is good, with a debt-to-equity ratio of 0.35.

The company's industry is growing, with an expected compound annual growth rate of 8%.

Sage's stock has a beta of 1.13, indicating a higher level of volatility compared to the market.

Worth a look: Dell Computer Ticker Symbol

Sage Therapeutics's revenue took a significant hit in 2024, decreasing by 52.30% to $41.24 million.

The company's losses also saw a notable reduction, decreasing by 26.01% to -$400.67 million.

In 2024, Sage Therapeutics's revenue was significantly lower than the previous year's $86.46 million.

For your interest: G1 Therapeutics Stock Symbol

Sage Therapeutics' financial performance has been quite underwhelming compared to the S&P, a benchmark of the overall stock market.

The company's stock has lost a significant amount of value over the past year, with a return of -65.97% compared to the S&P's 17.58%.

In fact, Sage Therapeutics' stock has been a major disappointment over the past five years, with a return of -88.23% compared to the S&P's 91.99%.

This translates to an annualized return of -34.82% for Sage Therapeutics, which is significantly lower than the S&P's 13.93% annualized return over the same period.

If you had invested in Sage Therapeutics since its IPO, you would have lost a whopping 75% of your investment, whereas the S&P has more than tripled in value over the same time period.

Here's a summary of the returns for both companies:

Sage Therapeutics's revenue took a significant hit in 2024, plummeting to $41.24 million, a staggering -52.30% decrease from the previous year's $86.46 million.

Losses were substantial, coming in at -$400.67 million, a -26.01% decrease compared to the previous year.

Sage Therapeutics has seen its share price fluctuate significantly over the past year, with a 1 Year Change of -66.90%.

The company's stock price has also experienced a 3 Month Change of 30.03%, a notable increase.

Sage Therapeutics' current share price is US$7.49, down from its 52 Week High of US$23.22.

The company's stock price has been volatile, with a 1 Month Change of 5.49%.

Here's a summary of Sage Therapeutics' price history over the past 5 years:

Since its IPO, Sage Therapeutics' share price has decreased by 75.03%.

Sage stock has seen significant price fluctuations over the past year, with a 1 Year Change of -66.90%.

The current share price of Sage Therapeutics is US$7.49, which is a 5.49% increase in the last month. This is a notable improvement from the 1 Year Change of -66.90%.

Here are some key stats to put Sage's price movement into perspective:

Sage's weekly volatility has been stable over the past year, but is still higher than 75% of US stocks, according to the article. This suggests that Sage's price movements are relatively volatile compared to the broader market.

Discover more: Stock Symbol B

Sage Therapeutics' stock price climbed 15.6% this week, but investors aren't impressed with the late-stage trial results for the company's major depressive disorder drug.

The biotech industry average movement is 10.9%, which is lower than SAGE's 12.5% average weekly movement.

SAGE's weekly volatility has been stable over the past year, but is still higher than 75% of US stocks, with a weekly movement of 13%.

SAGE's share price has been volatile over the past 3 months compared to the US market, with a 12.5% average weekly movement.

The 10% most volatile stocks in the US market have an average weekly movement of 17.8%, while the 10% least volatile stocks have an average weekly movement of 3.1%.

Recommended read: Subaru Stock Symbol

Sage Therapeutics stock is crashing today due to an even bigger regulatory loss that outweighed its regulatory win.

The company's regulatory win wasn't enough to offset the loss, showing that investors are looking for more than just one positive development.

Investors can see the finish line for the company's second marketed therapy, but it's unclear if this will be enough to stabilize the stock price.

Sage stock symbol is listed on the London Stock Exchange under the ticker code SGEO.

Sage is a global leader in cloud-based accounting and financial management solutions, serving over 3 million customers worldwide.

The company has a strong track record of innovation, with a history of acquiring and integrating complementary businesses to expand its offerings and reach new markets.

Sage Therapeutics took a hit this week after receiving bad news from the FDA. The company's shares slumped significantly.

Bad news from regulatory bodies can be a major blow to a company's stock. It's a clear warning sign that investors should pay attention to.

The FDA's decision likely had a direct impact on Sage Therapeutics' financials, leading to increased losses. This is a common outcome when a company receives unfavorable news from regulators.

Increased losses can be a significant concern for investors, making it a good time to reassess their portfolio.

Recommended read: News Corp Ticker Symbol

Biogen Inc. made an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics not already owned by Biogen.

The offer is for $7.22 per share, which led to a significant surge in Sage Therapeutics stock, with shares soaring nearly 40% on Monday.

This takeover bid is a significant development for both companies, and its outcome will likely have a substantial impact on their respective futures.

Sage Therapeutics stock is surging higher on Monday due to Biogen's proposal, a stark contrast to the usual market trends.

The proposal is a bold move by Biogen, and its success will depend on various factors, including the approval of Sage Therapeutics' shareholders and regulatory bodies.

Biogen's offer is a clear indication of the company's interest in expanding its portfolio and capabilities through strategic acquisitions.

Here's an interesting read: Juno Therapeutics Stock Symbol

Sage, with its stock symbol SAGE, is a leading provider of cloud-based accounting and business management solutions.

Sage's market share in the cloud accounting market is around 10%, making it a significant player in the industry.

The company's focus on innovation has led to the development of new solutions, such as Sage Business Cloud, which provides a range of tools for businesses to manage their finances, operations, and customer relationships.

Sage's revenue has been steadily increasing, with a growth rate of 5% in the last year.

A different take: Frost Bank Stock Market Symbol

Analysts are predicting a significant increase in SAGE stock, with an average rating of "Hold" from 20 experts.

The 12-month stock price forecast is $10.67, a 42.46% boost from the latest price.

This forecast suggests a promising future for SAGE stock, and investors are likely taking note of the potential gain.

Check this out: History of Stock Price Symbol Svm

The competition in the market is fierce, with several key players vying for dominance.

One of the main competitors is ABC Corporation, which has a strong presence in the market with a market share of 30%. Their products are known for their high quality and innovative features.

Another major competitor is DEF Company, which has been growing rapidly in recent years and now holds a market share of 25%. Their focus on sustainability and eco-friendliness has resonated with environmentally-conscious consumers.

XYZ Inc. is also a significant player in the market, with a market share of 20%. Their products are popular among budget-conscious consumers who value affordability without sacrificing quality.

These competitors are not only vying for market share, but also constantly innovating and improving their products to stay ahead of the curve.

If this caught your attention, see: Air Products Stock Symbol

Sage stock symbol is listed on the London Stock Exchange under the ticker symbol SGE.

Sage is a leading provider of cloud-based accounting, financial, and business management solutions for small and medium-sized businesses.

Sage's software helps businesses manage their finances, operations, and customer relationships more efficiently.

The company has a strong global presence with operations in over 25 countries.

Sage's cloud-based solutions are designed to help businesses scale and grow more effectively.

Sage's financial performance has been consistently strong over the years, with a significant increase in revenue and profitability.

Curious to learn more? Check out: Zepp Solutions Stock Ticker Symbol